Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia.

Blood - 25 Apr 2024

Leung Wingchi K, Torres Chavez Alejandro G, French-Kim Matthew, Shafer Paul, Mamonkin Maksim, Hill LaQuisa C, Kuvalekar Manik, Velazquez Yovana, Watanabe Ayumi, Watanabe Norihiro, Hoyos Valentina, Lulla Premal, Leen Ann M

Abstract excerpt

ABSTRACT: For patients with high-risk or relapsed/refractory acute myeloid leukemia (AML), allogeneic stem cell transplantation (allo-HSCT) and the graft-versus-leukemia effect mediated by donor T cells, offer the best chance of long-term remission. However, the concurrent transfer of alloreactive T cells can lead to graft-versus-host disease that is associated with transplant-related morbidity and mortality....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Neoplasm
Share to Hematopoietic Stem Cell Transplantation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunotherapy

Share to Isocitrate Dehydrogenase

Share to Leukemia, Myeloid, Acute

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 38241630
DOI: 10.1182/blood.2023021979
PMCID: PMC11103096

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia.PMID 38241630Read ↗

Driver mutation landscape of acute myeloid leukemia provides insights for neoantigen-based immunotherapy.Semantic proximity Read ↗

Identification of specific T-cell response and T-cell receptor targeting shared neoantigen for acute myeloid leukemia.Semantic proximity Read ↗

Neoantigens in Hematological Malignancies—Ultimate Targets for Immunotherapy?Semantic proximity Read ↗

CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia.Semantic proximity Read ↗

Neoantigen-Specific T-Cell Immune Responses: The Paradigm of NPM1-Mutated Acute Myeloid Leukemia.Semantic proximity Read ↗

Mutated <i>BCR-ABL</i> Generates Immunogenic T-cell Epitopes in CML PatientsSemantic proximity Read ↗

In Silico Analysis of the Minor Histocompatibility Antigen Landscape Based on the 1000 Genomes Project.Semantic proximity Read ↗

Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantationSemantic proximity Read ↗

Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells.Semantic proximity Read ↗

Beneath the Surface: Neoantigens beyond Chromosomal DNA Mutations.Semantic proximity Read ↗

Mis-splicing-derived neoantigens and cognate TCRs in splicing factor mutant leukemias.Semantic proximity Read ↗

Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.